Adaptive Biotechnologies Corp (ADPT)
3.01
+0.08
(+2.73%)
USD |
NASDAQ |
May 03, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Gross Profit Margin (Quarterly): 57.16% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 57.16% |
September 30, 2023 | 48.98% |
June 30, 2023 | 63.39% |
March 31, 2023 | 50.38% |
December 31, 2022 | 69.95% |
September 30, 2022 | 68.83% |
June 30, 2022 | 69.72% |
March 31, 2022 | 65.84% |
December 31, 2021 | 62.15% |
September 30, 2021 | 64.05% |
June 30, 2021 | 72.04% |
March 31, 2021 | 74.01% |
Date | Value |
---|---|
December 31, 2020 | 79.39% |
September 30, 2020 | 76.98% |
June 30, 2020 | 76.60% |
March 31, 2020 | 74.45% |
December 31, 2019 | 75.42% |
September 30, 2019 | 78.51% |
June 30, 2019 | 74.10% |
March 31, 2019 | 60.62% |
December 31, 2018 | 69.32% |
September 30, 2018 | 68.82% |
June 30, 2018 | 56.40% |
March 31, 2018 | 58.94% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
48.98%
Minimum
Sep 2023
79.39%
Maximum
Dec 2020
68.52%
Average
69.95%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 48.70% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -57.64% |
Return on Assets | -29.71% |
Return on Invested Capital | -57.64% |
Profit Margin (Quarterly) | -151.7% |
Operating Margin (Quarterly) | -99.68% |
Return on Net Operating Assets | -68.39% |